We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KO:NYSECoca-Cola Company (The) Analysis

Data as of 2026-05-19 - not real-time

$81.98

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The Coca‑Cola stock is trading at $81.98, essentially at its 52‑week high of $82.66 and just above the 20‑day SMA of $78.68, indicating strong recent momentum. Technical indicators are mixed: the MACD line sits above its signal (bullish) and the histogram is positive, but the 14‑day RSI of 71.9 signals the stock is overbought and vulnerable to a short‑term pullback. The price is hugging the identified resistance level of $82.66 while a solid support zone sits near $74.55, and the 30‑day volatility of 18 % suggests price swings can be sizable. The beta of –0.07 (computed) and a quoted beta of 0.36 point to low market‑directional risk, reinforcing the defensive nature of the consumer‑staples sector.
Fundamentally, Coca‑Cola posted 12 % revenue growth YoY, with robust gross (61.7 %) and operating margins (35 %). Return on equity is an impressive 43 % and free cash flow exceeds $3.1 bn, underpinning a 2.61 % dividend yield and a payout ratio of roughly 65 %. However, the DCF‑derived fair value of $8.48 per share and a modest upside of 4.6 % signal that the market may be pricing the stock at a premium. The balance sheet shows high leverage (debt‑to‑equity ≈125 %) but ample cash reserves, while the recent launch of Fresca Hard expands the ready‑to‑drink portfolio, offering an additional growth catalyst.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI in overbought territory
  • Price near 52‑week high and resistance
  • High valuation relative to DCF

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Consistent revenue growth and strong margins
  • New product launch (Fresca Hard) expanding portfolio
  • Defensive sector with stable dividend

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable brand moat and global distribution network
  • Sustainable dividend yield and cash‑flow generation
  • Long‑term defensive positioning despite leverage

Key Metrics & Analysis

Financial Health

Revenue Growth12.10%
Profit Margin27.80%
P/E Ratio25.8
ROE43.37%
ROA9.51%
Debt/Equity124.94
P/B Ratio10.5
Op. Cash Flow$14.6B
Free Cash Flow$3.1B

Technical Analysis

TrendBullish
RSI71.9
Support$74.55
Resistance$82.66
MA 20$78.68
MA 50$77.22
MA 200$72.58
MACDBullish
VolumeStable
Fear & Greed Index89.11

Valuation

Fair Value$8.48
Target Price$85.76
Upside/Downside4.61%
GradeOvervalued
TypeBlend
Dividend Yield2.61%

Risk Assessment

Beta-0.07
Volatility18.01%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.